GGrantIndex
Sort

326,823 grants matching clinical trial

Hematopoietic Cell Transplantation for Hematologic Malignancies

$2,987,761
Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA

BASE PERIOD 03/08/2013 - 09/07/2013 STORAGE AND DISTRIBUTION OF CLINICAL AGENTS H

$2,987,324
Young Kim · Fisher Bioservices, Inc. · N02 · FY2015 · CA

UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT

$2,986,884
University Of Alabama At Birmingham · U01 · FY2004 · AI

Autonomic Pharmacodynamic Pharmacogenomics

$2,986,871
University Of California San Diego · U01 · FY2004 · HL

Chemoprophylaxis for HIV Prevention in Men

$2,986,662
Robert M. Grant · J. David Gladstone Institutes · U01 · FY2006 · AI

Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury

$2,986,554
Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR

LUM-001 as a Treatment for Creatine Transporter Deficiency

$2,986,326
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR

B-Lymphocyte Immunotherapy in Islet Transplantation

$2,985,767
University Of Pennsylvania · U01 · FY2005 · DK

SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE (UL1)

$2,985,526
Eric Jeffrey Topol · Scripps Research Institute, The · UL1 · FY2011 · RR

Structural Cell Biology of DNA Repair Machines

$2,985,088
John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2022 · CA

Comprehensive Liquid Biomarkers to Personalize Therapy in Renal Cell Carcinoma

$2,984,495
Rana Ramzi McKay · University Of California, San Diego · R01 · FY2025 · CA

Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD Cohort

$2,984,023
Marilyn S Albert · Johns Hopkins University · U19 · FY2016 · AG

Clinical Studies of Vaccines for Pandemic Influenza

$2,983,617
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

KY IDeA Networks of Biomedical Research Excellence

$2,982,983
Nigel G Cooper · University Of Louisville · P20 · FY2010 · RR

Impact of Asymptomatic CMV on Cardiovascular Event Risk in Treated HIV

$2,981,544
Peter W Hunt · University Of California, San Francisco · R01 · FY2025 · HL

Lung Transplant Clinical Trial Network (LT-CTN)

$2,981,212
Scott M Palmer · Duke University · U01 · FY2021 · AI

Phase II Clinical Trial to Evaluate a Vaccine Candidate for Gonococcal Infection

$2,981,138
National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI

Data Resource for Analyzing Blood &Marrow Transplants

$2,980,766
Medical College Of Wisconsin · U24 · FY2005 · CA

WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSIS

$2,980,765
Emory University · R01 · FY2001 · NS

PROMISE Trial: Clinical Coordinating Center

$2,980,313
Pamela Susan Douglas · Duke University · R01 · FY2012 · HL

Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH)

$2,980,290
Paul A. Harris · Vanderbilt University Medical Center · U24 · FY2016 · TR

Models, signals, and distributed bio-behavioral control of exercise in diabetes

$2,979,886
Marc D Breton · University Of Virginia · DP3 · FY2015 · DK

FIM+DASH: A randomized Food Is Medicine trial to promote healthy eating and blood pressure control in hypertensive Black women with obesity

$2,979,575
Saria Lofton · University Of Illinois At Chicago · R01 · FY2025 · MD

Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma

$2,978,876
Scott T Weiss · Brigham And Women'S Hospital · UH3 · FY2019 · OD

Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases

$2,978,290
Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI